ArticleBlood cancer journal2021

Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia.

Yu-Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.